RGC
Regencell Bioscience Holdings Limited Ordinary Shares (RGC)
$63
About Regencell Bioscience Holdings Limited Ordinary Shares (RGC)
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
Details
Daily high
$64.72
Daily low
$50.03
Price at open
$53.70
52 Week High
$64.72
52 Week Low
$3.03
Market cap
762.9M
Dividend yield
0.00%
Volume
969,488
Avg. volume
1.9M
P/E ratio
-177.34
Regencell Bioscience Holdings Limited Ordinary Shares News
Details
Daily high
$64.72
Daily low
$50.03
Price at open
$53.70
52 Week High
$64.72
52 Week Low
$3.03
Market cap
762.9M
Dividend yield
0.00%
Volume
969,488
Avg. volume
1.9M
P/E ratio
-177.34